Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Change in Receivables of -$6.2 million in Q2 2018, little changed quarter-over-quarter from -$6.2 million in Q1 2018.
Corbus Pharmaceuticals Holdings (CRBP) Change in Receivables (2017 - 2018) Analysis & Trends
Corbus Pharmaceuticals Holdings' Change in Receivables history runs 2 years deep, the most recent figure standing at -$6.2 million for Q2 2018.
- In Q2 2018, Change in Receivables changed N/A year-over-year to -$6.2 million; the TTM figure through Sep 2019 stood at -$6.2 million (up 51.92% YoY), while the FY2019 annual figure was -$5.0 million, up 60.0% from the prior year.
- Change in Receivables was -$6.2 million for Q2 2018 at Corbus Pharmaceuticals Holdings, roughly flat from -$6.2 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $500000.0 in Q3 2017 to a low of -$6.2 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -6.25 Mn |
| Jun 30, 2018 | -6.25 Mn |
| Mar 31, 2018 | -6.25 Mn |
| Mar 31, 2018 | -6.25 Mn |
| Dec 31, 2017 | -500,000.00 |
| Dec 31, 2017 | -500,000.00 |
| Sep 30, 2017 | 500,000.00 |
| Sep 30, 2017 | 500,000.00 |
| Mar 31, 2017 | -1.00 Mn |
| Mar 31, 2017 | -1.00 Mn |